Previous Close | 37.60 |
Open | 37.87 |
Bid | 38.55 x 4000 |
Ask | 38.57 x 38500 |
Day's Range | 37.81 - 38.70 |
52 Week Range | 29.99 - 43.08 |
Volume | 52,829,481 |
Avg. Volume | 31,922,751 |
Market Cap | 215.15B |
Beta (5Y Monthly) | 0.65 |
PE Ratio (TTM) | 22.60 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.56 (4.04%) |
Ex-Dividend Date | Jan 28, 2021 |
1y Target Est | N/A |
Britain's biggest hospitality firms also called on prime minister Boris Johnson to stick with the current dates on the roadmap out of lockdown.
Biotech startups Repare Therapeutics and Ideaya Biosciences, along with Big Pharma partners, are now leading clinical trials for new drugs.
It's been 13 months since Pfizer (NYSE: PFE) announced that it was partnering with BioNTech to develop a COVID-19 vaccine. Since then, Pfizer's shares are up more than 26%. Should you buy Pfizer in April?